FDA Investigator Finn A Slizza

Finn A Slizza has conducted inspections on 48 sites in 3 countries as of 08 Apr 2003. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
48
Last Inspection Date:
08 Apr 2003
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Germany, France
FDA Investigators that have inspected at least one site in common with Finn A Slizza:
Aaron J Adler, Abraham M Maekele, Ademola O Daramola, Albert Rodriguez, Alexandria L Capuano, Allen F Hall, Althea A Williams, Anderson, Angela Shepas, Angelica G Aziz, Arsen Karapetyan, Bichsa T Tran, Bryan A Galvez, Burnsb, Carla J Lundi, Cathleen A Carr Sharpe, CDR Sean T Creighton, Celena Ngo, Charles L Larson, Chelsea N Sealey, Cheryl D Mccall, Chorng M Cheng, Christian D Lynch (CDL), Christopher M Jenner, Cynthia L Gorveatt, Dannie E Rowland, Darren S Brown, Deborah A Greco, Dejon N Harris, Diane Cvan Leeuwen, Doan T Nguyen, PharmD, Dolores Harper, Donna Ltartaglino Besone, Dr. Guang Gao, PhD, Durell L Giles, Esther B Gamallo Herrera, Francis J Eng, Garciam, Gary L Zaharek, Gene D Arcy, Geraldine M Peregrin, Herminio C Francisco, J Elkins, Jacqueline C Sram, James A Lane, James E Bentson, James P Stallings, James R Fleckenstein, James R Montero, Janet Pulver, Jasmine N Thompson, Jenny L Chisem, Jenny L Mccardell, Jinnie Kokiatkulkij, Jocelyn E Massey, Jocelyn E Sparks, Joey V Quitania, John A Gonzalez, Joshua J Silvestri, Juanita Banuelos, Juanj N Wu, Judy C Nepsa, Kaarin M Slotte, Kari M Johansen, Katherine E Jacobitz, Kelvin Cheung, Kevin N Tran, Kham Phommachanh, Kirtida Patel, Lanita F Kelley, Laverne Kimble, Leighton Kn Gai, Leo J Lagrotte, Leonard H Lavi, Lilly O Barton, Liming Zhang, Linda Galindo, Linda Linh N Adams, Linda Thai, M Jasnethoson Thompson, Maria Isabe Tejero Del Rio, Mariza M Jafary, Mark C Saale, Mary Ewilkerson Brinsko, Matthew M Vernon, Mei Chen Mu, Miaja Umaedi, Michael D Garcia, Michael Garcia, Michael S Araneta, Minh D Phan, Naveen B Walker, Norman Wong, Omotunde O Osunsanmi, Paquita F Segarra, Paula A Trost, Prabhu P Raju, Rafael A Kaup, Richard K Vogel, Richard W Tubb, Richmond K Yip, Santiago Gallardo Johnson, Sara Jdent Acosta, Scott K Zika, Selene T Torres, Shaquenta Y Perkins, Sharon I Gundersen, Sonya L Karsik, RAC, Steven E Porter, Jr, Sumit Sen, Sunitha K Rajaram, PhD, Suzie L Kent, Tamala P Magee, Terrance L Thomas, Thanh M Andrews, Thao T Kwan, Theresa Kirkham (NMI), Thomas R Beilke, Trang N Cox, Travis S Bradley, Trudy R Papson, Truong Xuan Nguyen (Andy), Uros V Djekic, PhD, Vasant G Malshet, PhD, Vashti E Bocker, Vickie L Anderson, Victor H Loo, Virgilio F Pacio, CSO, Walden H Lee, William S Vitale, Wr Bowman, Yvette E Guillermo, Yvette Mlacour Davis, Zachary L Miller

Finn A Slizza's Documents

Publish Date Document Type Title
January, 2002 EIR Avi Corp - EIR, 2002-01-11
November, 2000 FDA 483 Response Medline Industries, Inc. - Form 483R, 2001-04-12
August, 2000 EIR CareFusion 303, Inc. - EIR, 2000-08-04
November, 2000 EIR Medline Industries, Inc. - EIR, 2000-11-03
April, 2003 EIR Abbott Vascular Inc - EIR, 2003-04-16
August, 2000 FDA 483 CareFusion 303, Inc. - Form 483, 2000-08-04
April, 2000 EIR North American Science Associates, LLC - EIR, 2000-04-27
November, 2000 FDA 483 Medline Industries, Inc. - Form 483, 2000-11-03

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more